Skip to main content

Advertisement

Log in

Patterns and Correlates of Prescription Opioid Receipt Among US Veterans: A National, 18-Year Observational Cohort Study

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

A better understanding of predisposition to transition to high-dose, long-term opioid therapy after initial opioid receipt could facilitate efforts to prevent opioid use disorder (OUD). We extracted data on 69,268 patients in the Veterans Aging Cohort Study who received any opioid prescription between 1998 and 2015. Using latent growth mixture modelling, we identified four distinguishable dose trajectories: low (53%), moderate (29%), escalating (13%), and rapidly escalating (5%). Compared to low dose trajectory, those in the rapidly escalating dose trajectory were proportionately more European-American (59% rapidly escalating vs. 38% low); had a higher prevalence of HIV (31% vs. 29%) and hepatitis C (18% vs. 12%); and during follow-up, had a higher incidence of OUD diagnoses (13% vs. 3%); were hospitalised more often [18.1/100 person-years (PYs) vs. 12.5/100 PY]; and had higher all-cause mortality (4.7/100 PY vs. 1.8/100 PY, all p < 0.0001). These measures can potentially be used in future prevention research, including genetic discovery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Dobscha SK, Corson K, Flores JA, Tansill EC, Gerrity MS. Veterans Affairs Primary Care Clinicians’ attitudes toward chronic pain and correlates of opioid prescribing rates. Pain Med. 2008;9(5):564–71.

    Article  PubMed  Google Scholar 

  2. Gironda RJ, Clark ME, Massengale JP, Walker RL. Pain among Veterans of Operations Enduring Freedom and Iraqi Freedom. Pain Med. 2006;7(4):339–43.

    Article  PubMed  Google Scholar 

  3. Fayaz A, Croft P, Langford RM, Donaldson LJ, Jones GT. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open. 2016;6(6):e010364.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R, Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med. 2010. https://doi.org/10.1001/archinternmed.2010.391.

    Article  PubMed  Google Scholar 

  5. Bohnert ASB, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. J Am Med Assoc. 2011;305(13):1315–21.

    Article  CAS  Google Scholar 

  6. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, et al. Opioid prescriptions for chronic pain and overdose. Ann Intern Med. 2010;152:85–92.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Dowell D, Haegerich T, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. J Am Med Assoc. 2016. https://doi.org/10.1001/jama.2016.1464.(epub).

    Article  Google Scholar 

  8. The Opioid Therapy for Chronic Pain Work Group. In: Department of Veterans Affairs, Department of Defense, editors. VA/DoD clinical practice guideline for opioid therapy for chronic pain. 2017.

  9. Dowell D, Haegerich T, Chou R. CDC guideline for prescribing opioids for chronic pain—United States 2016. MMWR Recomm Rep. 2016;65(No. RR-1):1–49.

    Article  PubMed  Google Scholar 

  10. Faculty of Pain Medicine. Opioids aware: a resource for patients and healthcare professionals to support prescribing of opioid medicines for pain. http://www.fpm.ac.uk/faculty-of-pain-medicine/opioids-aware. Accessed 8 Jun 2019.

  11. Hauser W, Bock F, Engeser P, Hege-Scheuing G, Huppe M, Lindena G, et al. Recommendations of the updated LONTS guidelines. Long-term opioid therapy for chronic noncancer pain. Schmerz. 2015;29(1):109–30.

    Article  CAS  PubMed  Google Scholar 

  12. Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK. Clinical characteristics of Veterans prescribed high doses of opioid medications for chronic non-cancer pain. PAIN®. 2010;151(3):625–32.

    Article  Google Scholar 

  13. Sullivan MD, Edlund MJ, Fan M-Y, DeVries A, Braden JB, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and Medicaid insurance plans: the TROUP Study. Pain. 2008;138(2):440–9.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Edlund MJ, Martin BC, Fan M-Y, Braden JB, Devries A, Sullivan MD. An analysis of heavy utilizers of opioids for chronic noncancer pain in the TROUP Study. J Pain Symptom Manag. 2010;40(2):279–89.

    Article  Google Scholar 

  15. Gelernter J, Kranzler HR, Sherva R, Koesterer R, Almasy L, Zhao H, et al. Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways. Biol Psychiatry. 2014;76(1):66–74.

    Article  CAS  PubMed  Google Scholar 

  16. Cheng Z, Zhou H, Sherva R, Farrer LA, Kranzler HR, Gelernter J. Genome-wide association study identifies a regulatory variant of RGMA associated with opioid dependence in European Americans. Biol Psychiatry. 2018. https://doi.org/10.1016/j.biopsych.2017.12.016.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Nelson EC, Agrawal A, Heath AC, Bogdan R, Sherva R, Zhang B, et al. Evidence of CNIH3 involvement in opioid dependence. Mol Psychiatry. 2015. https://doi.org/10.1038/mp.2015.102.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Li D, Zhao H, Kranzler HR, Li MD, Jensen KP, Zayats T, et al. Genome-wide association study of copy number variations (CNVs) with opioid dependence. Neuropsychopharmacology. 2015;40(4):1016–26.

    Article  CAS  PubMed  Google Scholar 

  19. Smith AH, Jensen KP, Li J, Nunez Y, Farrer LA, Hakonarson H, et al. Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1. Mol Psychiatry. 2017;22(3):346–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Edelman EJ, Gordon K, Becker WC, Goulet JL, Skanderson M, Gaither JR, et al. Receipt of opioid analgesics by HIV-infected and uninfected patients. J Gen Intern Med. 2013;28(1):82–90.

    Article  PubMed  Google Scholar 

  21. Becker WC, Gordon K, Edelman EJ, Kerns RD, Crystal S, Dziura JD, et al. Trends in any and high-dose opioid analgesic receipt among aging patients with and without HIV. AIDS Behav. 2016;20(3):679–86.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Weisberg DF, Gordon KS, Barry DT, Becker WC, Crystal S, Edelman EJ, et al. Long-term prescription of opioids and/or benzodiazepines and mortality among HIV-infected and uninfected patients. J Acquir Immune Defic Syndr. 2015;69(2):223–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Edelman EJ, Gordon KS, Crothers K, Akgun K, Bryant KJ, Becker WC, et al. Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV. JAMA Intern Med. 2019. https://doi.org/10.1001/jamainternmed.2018.6101.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Wiese AD, Griffin MR, Schaffner W, Stein CM, Greevy RA, Mitchel EF Jr, et al. Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case–control study. Ann Intern Med. 2018;168(6):396–404.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Fultz SL, Skanderson M, Mole L, Gandhi N, Bryant K, Crystal S, et al. Development and verification of a “virtual” cohort using the national VA Health Information System. Med Care. 2006;44(8):S25–30.

    Article  PubMed  Google Scholar 

  26. Justice AC, Dombrowski E, Conigliaro J, Fultz SL, Gibson D, Madenwald T, et al. Veterans Aging Cohort Study (VACS): overview and description. Med Care. 2006;44(8):S13–24.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Justice AC, Modur S, Tate J, Althoff K, Jacobson LP, Gebo KA, et al. Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr. 2013;62(2):149–63.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Akgun KM, Gordon K, Pisani M, Fried T, McGinnis KA, Tate JP, et al. Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr. 2013;62(1):52–9.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Akgun KM, Tate JP, Crothers K, Crystal S, Leaf DA, Womack J, et al. An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals. J Acquir Immune Defic Syndr. 2014;67(4):397–404.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Escota GV, Patel P, Brooks JT, Bush T, Conley L, Baker J, et al. Short communication: the Veterans Aging Cohort Study Index is an effective tool to assess baseline frailty status in a contemporary cohort of HIV-infected persons. AIDS Res Hum Retroviruses. 2015;31(3):313–7.

    Article  CAS  PubMed  Google Scholar 

  31. Marquine MJ, Umlauf A, Rooney AS, Fazeli PL, Gouaux BD, Paul Woods S, et al. The Veterans Aging Cohort Study index is associated with concurrent risk for neurocognitive impairment. J Acquir Immune Defic Syndr. 2014;65(2):190–7.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Tate JP, Justice AC, Hughes MD, Bonnet F, Reiss P, Mocroft A, et al. An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS. 2013;27(4):563–72.

    Article  PubMed  Google Scholar 

  33. Womack JA, Goulet JL, Gibert C, Brandt CA, Skanderson M, Gulanski B, et al. Physiologic frailty and fragility fracture in HIV-infected male Veterans. Clin Infect Dis Off Publ Infect Dis Soc Am. 2013;56(10):1498–504.

    Article  Google Scholar 

  34. Altman M. In: Lewis-Beck M, Bryman AE, Liao TF, editors. Encyclopedia of social science research methods. Thousand Oaks: Sage Publications; 2004.

    Google Scholar 

  35. Jones BL, Nagin DS. Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociol Methods Res. 2007;35(4):542–71.

    Article  Google Scholar 

  36. Jones BL, Nagin DS, Roeder K. A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res. 2001;29(3):374–93.

    Article  Google Scholar 

  37. Nagin D. Group-based modeling of development. Cambridge: Harvard University Press; 2005.

    Book  Google Scholar 

  38. Palmer RH, Brick L, Nugent NR, Bidwell LC, McGeary JE, Knopik VS, et al. Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependence. Addiction. 2015;110(3):530–7.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Goulet JL, Brandt C, Crystal S, Fiellin DA, Gibert C, Gordon AJ, et al. Agreement between electronic medical record-based and self-administered pain numeric rating scale: clinical and research implications. Med Care. 2013;51(3):245–50.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, et al. Assessment of pain. Br J Anaesth. 2008;101(1):17–24.

    Article  CAS  PubMed  Google Scholar 

  41. Banta-Green CJ, Merrill JO, Doyle SR, Boudreau DM, Calsyn DA. Opioid use behaviors, mental health and pain—development of a typology of chronic pain patients. Drug Alcohol Depend. 2009;104(1–2):34–42.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Gagnon B, Scott S, Nadeau L, Lawlor PG. Patterns of community-based opioid prescriptions in people dying of cancer. J Pain Symptom Manag. 2015;49(1):36–44.e1.

    Article  Google Scholar 

  43. Guarino H, Marsch LA, Deren S, Straussner SL, Teper A. Opioid use trajectories, injection drug use, and hepatitis C virus risk among young adult immigrants from the Former Soviet Union living in New York City. J Addict Dis. 2015;34(2–3):162–77.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Hser YI, Huang D, Saxon AJ, Woody G, Moskowitz AL, Matthews AG, et al. Distinctive trajectories of opioid use over an extended follow-up of patients in a multisite trial on buprenorphine + naloxone and methadone. J Addict Med. 2017;11(1):63–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Monga N, Rehm J, Fischer B, Brissette S, Bruneau J, El-Guebaly N, et al. Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug Alcohol Depend. 2007;88(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  46. Naumann RB, Marshall SW, Gottfredson NC, Lund JL, Ringwalt CL, Skinner AC. Trajectories of dispensed prescription opioids among beneficiaries enrolled in a Medicaid controlled substance “lock-in” program. Pharmacoepidemiol Drug Saf. 2018. https://doi.org/10.1002/pds.4445.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Barnett ML, Olenksi AR, Jena AB. Opioid prescribing by emergency physicians and risk of long-term use. N Engl J Med. 2017;376(19):1896.

    PubMed  Google Scholar 

  48. Burgess DJ, Nelson DB, Gravely AA, Bair MJ, Kerns RD, Higgins DM, et al. Racial differences in prescription of opioid analgesics for chronic noncancer pain in a national sample of Veterans. J Pain. 2014;15(4):447–55.

    Article  PubMed  Google Scholar 

  49. Hoffman KM, Trawalter S, Axt JR, Oliver MN. Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites. Proc Natl Acad Sci USA. 2016;113(16):4296–301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Schranz AJ, Barrett J, Hurt CB, Malvestutto C, Miller WC. Challenges facing a rural opioid epidemic: treatment and prevention of HIV and hepatitis C. Curr HIV/AIDS Rep. 2018;15(3):245–54.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Ogdie A, Pang WG, Forde KA, Samir BD, Mulugeta L, Chang KM, et al. Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection. BMC Musculoskelet Disord. 2015;16:93.

    Article  PubMed  PubMed Central  Google Scholar 

  53. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Publishers; 2013.

  54. Dowell D, Haegerich T, Chou R. No shortcuts to safer opioid prescribing. N Engl J Med. 2019. https://doi.org/10.1056/NEJMp1904190.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE Randomized Clinical Trial. JAMA. 2018;319(9):872–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by US National Institutes of Health, including Grants from National Institute on Alcohol Abuse and Alcoholism (U24-AA020794, U01-AA020790, U10-AA013566-completed to ACJ) and National Institute on Drug Abuse (NIDA R01-DA040471, R01-DA12690). Additional support was provided by the US Department of Veterans Affairs (i01-BX003341), Yale School of Medicine Drug Use, Addiction, and HIV Research Scholars Program (DAHRS K12-DA033312), and Agency for Healthcare Research and Quality (AHRQ U19-HS021112 and R18-HS023258). The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The views presented in this paper are the authors’ and not necessarily those of the Department of Veterans Affairs or the United States Government.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Christopher T. Rentsch.

Ethics declarations

Conflict of interest

Dr. Kranzler is a Member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative, which was supported in the last 3 years by AbbVie, Alkermes, Ethypharm, Indivior, Lilly, Lundbeck, Otsuka, Pfizer, and XenoPort. Drs. Kranzler, Gelernter, and A. Smith are also named as Inventors on PCT Patent Application #15/878,640 entitled: “Genotype-guided dosing of opioid agonists,” filed January 24, 2018. The remaining authors have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rentsch, C.T., Edelman, E.J., Justice, A.C. et al. Patterns and Correlates of Prescription Opioid Receipt Among US Veterans: A National, 18-Year Observational Cohort Study. AIDS Behav 23, 3340–3349 (2019). https://doi.org/10.1007/s10461-019-02608-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-019-02608-3

Keywords

Navigation